AUS
NZ
UK
CA
USA
IND
Healthcare
Why CSL Shares Are Drawing Fresh Attention on the ASX
May 28, 2026 02:50 PM AEST| By SamCSL shares remain in focus as healthcare demand, global expansion, and interest in ASX dividend stocks continue to support attention toward the biotechnology giant.
Why CSL’s Sharp Slide Is Putting the Healthcare Giant Back in Focus
May 28, 2026 02:00 PM AEST| By SamCSL shares remain closely watched as the biotechnology giant navigates valuation pressure and long-term healthcare growth trends.
Why ASX 200 Healthcare Stock Telix Pharmaceuticals Is Drawing Fresh Market Attention
May 28, 2026 10:02 AM AEST| By SamTelix Pharmaceuticals Ltd (ASX:TLX) gained attention after advancing its glioblastoma therapy program, with investors closely watching radiopharmaceutical growth opportunities, clinical trial progress, and the company’s expanding neuro-oncology strat...
Recce Pharmaceuticals Expands Reach Across MENA Healthcare Markets
May 27, 2026 07:31 PM AEST| By SamRecce Pharmaceuticals expands into the MENA healthcare market with a long-term licensing arrangement for diabetic foot infection treatment, strengthening focus on pharmaceutical innovation and regional healthcare accessibility.
What Sets Top ASX Healthcare Stocks Apart in 2026
May 27, 2026 06:15 PM AEST| By SamASX healthcare stocks require analysis of product technology, research investment, geographic reach, competitive strength, reimbursement settings, regulation and capital allocation across global healthcare markets.
Why ASX Healthcare Shares Keep Testing Market Nerves
May 27, 2026 05:49 PM AEST| By SamASX healthcare shares face risks from regulation, currency swings, operational costs, and competition, with CSL volatility highlighting why diversification and sector awareness remain important across Australian healthcare portfolios.
ASX 200 Healthcare Stocks: Key Aussie Sector Leaders
May 27, 2026 05:47 PM AEST| By SamASX healthcare stocks span biotherapies, medical devices, diagnostics, software, hospitals and specialty biotechnology, offering defensive exposure shaped by innovation, regulation, global demand and company execution.
Cochlear Strengthens Healthcare Market Presence Amid Industry Focus
May 27, 2026 02:56 PM AEST| By SamCochlear’s market position, healthcare sector strength, and global hearing solutions business continue drawing attention across the [ASX 100] and broader Australian equities market.
Why Tech Stocks Outshone Banks on a Tense ASX Stock Day
May 27, 2026 01:55 PM AEST| By SamAustralian technology stocks gained momentum while financial shares weakened as oil prices, geopolitical tensions, and global growth themes reshaped market sentiment across several key sectors.
Could Memphasys Be the Next Fertility Tech Story to Watch?
May 27, 2026 11:46 AM AEST| By SamMemphasys has drawn market attention after Felix cartridge developments highlighted growing commercial momentum and broader interest in fertility-focused healthcare technologies within Australia’s biotechnology sector.
What’s Fueling Fresh Buzz Around Aroa BioSurgery?
May 26, 2026 05:51 PM AEST| By SamAroa BioSurgery continues expanding within regenerative healthcare as innovation, hospital adoption trends and healthcare demand shape attention across the Australian healthcare sector.
ASX Biotech Stocks: Big Rewards, Bigger Risks
May 26, 2026 04:12 PM AEST| By SamBiotechnology investments offer the highest potential returns in healthcare alongside the highest failure rates, demanding specialised evaluation approaches from Australian investors.
PainChek (ASX:PCK) Appoints Lilian Bianchi as Director Amid Digital Health Expansion
May 26, 2026 04:10 PM AEST| By SamHighlights,• PainChek Ltd (ASX:PCK) appointed Lilian Bianchi as Director effective 25 May 2026.,• Appendix 3X filing disclosed nil initial holdings in PCK securities.,• PCK shares remained flat at AUD 0.15 following the announcement.,• The update is...
Why Healthcare Stocks Can Surprise ASX Investors
May 26, 2026 04:09 PM AEST| By SamHealthcare investments face regulatory, innovation, pricing and operational risks that require diversification, long-term positioning and ongoing monitoring across evolving healthcare markets.
Why Healthcare Stocks Keep Drawing Market Attention
May 26, 2026 04:06 PM AEST| By SamHealthcare stocks continue attracting market attention through demographic growth, biotechnology innovation, essential demand and expanding global healthcare services, making the sector one of the most influential parts of the Australian market.
Oil Shock Rattles ASX 200 Today as Market Mood Turns Fragile
May 26, 2026 02:09 PM AEST| By SamAustralian shares weakened as oil price volatility and geopolitical tensions pressured market sentiment, with property and financial stocks dragging lower while selected healthcare and retail companies managed to outperform.
Healthcare Giant Surges After Strong FY26 Earnings Beat
May 26, 2026 11:15 AM AEST| By SamFisher & Paykel Healthcare surged after delivering strong FY26 earnings growth, improving margins, and continued momentum across respiratory care and sleep therapy markets.
Why This Healthcare Giant Is Surging On FY26 Results
May 26, 2026 11:09 AM AEST| By SamFisher & Paykel Healthcare shares surged after strong FY26 earnings, improving margins, and continued growth across respiratory care and sleep therapy markets.
Why Ryman Healthcare’s Turnaround Is Starting to Look Real
May 26, 2026 10:03 AM AEST| By SamRyman Healthcare has returned to focus as stronger free cash flow, improving aged care profitability, and balance sheet recovery strengthen confidence in the company’s long-term operational turnaround.
CSL Share Price Outlook: Key Metrics Shaping Investor Focus
May 25, 2026 03:41 PM AEST| By SamExplore how CSL’s financial performance, healthcare leadership, and global operations continue shaping market attention across the Australian share market and major healthcare indices.
Advertise your brand on Kalkine Media